Home > PJ (current issue) > Original papers

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7406 p754-756
24 June 2006

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Original papers

A community pharmacy minor ailment scheme — effective, rapid and convenient

By Samir Vohra


Samir Vohra, MRPharmS, is community pharmacy development specialist at Chorley & South Ribble Primary Care Trust, Jubilee House, Lancashire Business Park, Centurion Road, Leyland, Lancashire PR1 6UU
e-mail samir.vohra@chorley-pct.nhs.uk

Abstract

Aim
To determine patients' views on a minor ailment scheme (MAS) in order to inform future service development.

Design
Confidential questionnaire survey

Subjects and setting
Patients who had accessed the Chorley & Ribble Primary Care Trust MAS in its first six months and who had given their consent to participate.

Results
Almost all respondents were positive about the scheme, will use it again and will recommend it to others. Respondents liked the scheme because they were now able to get free medicines at the pharmacy without recourse to a GP prescription (97%), and because they did not have to make an appointment with the GP (96%). Most respondents appreciated that the scheme gave them the choice of having their minor ailment treated elsewhere (93%) and they could get medical advice without going to a surgery (88%). Most respondents agreed the scheme saved them time, it was easier to see the pharmacist than the GP and their access to treatment had improved. Where minor ailment treatment and advice on medicines are concerned, around 70% of respondents are equally satisfied with consulting a pharmacist as they would be with consulting their GP. However, almost 25% of respondents expressed uncertainty on this. Nevertheless 93% of respondents would return to a pharmacist for treatment of a minor ailment. While most respondents considered the range of illnesses covered by the scheme satisfactory, half wanted further conditions added.

Conclusions
People who have accessed the MAS found it to be effective in terms of providing rapid and convenient access to advice and treatment.

Back to Top


©The Pharmaceutical Journal